Will deep-brain stimulation be as successful in major depression as it has been in Parkinson’s disease?

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors thank Joachim Klosterkötter, Head of the Department of Psychiatry and Psychotherapy and Dean of the Medical Faculty of the University of Cologne, and Dipl.-Psych. Theo OJ Gründler from the Max Planck Research Group ‘Cognitive Neurology’ at the Max Planck Institute for Neurological Research in Cologne for their valuable support in compiling this article.

In order to assure a stylistic faultless English the manuscript was edited by native speakers.

Financial & competing interests disclosure

Jens Kuhn received financial assistance from AstraZeneca for traveling to congresses and received honoraria from Lundbeck for lecturing at conferences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.